COVID-19 Impact on Global Insomnia Therapy Market Size, Status and Forecast 2020-2026

September 2020 | 126 pages | ID: C5A1920AEC3AEN
QYResearch

Abstracts

This report focuses on the global Insomnia Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Insomnia Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Merck & Co.
• Sanofi
• Pfizer
• Takeda Pharmaceutical Company Ltd.
• Purdue Pharmaceuticals L.P.
• Eisai, Co. Ltd.
• Meda Consumer Healthcare
• Pernix Therapeutics
• Vanda Pharmaceuticals
• ECR Pharmaceuticals
• Fidia Farmaceutici
• Dainippon Sumitomo
• Biocodex
• Eli Lilly and Company
• Ebb Therapeutics

Market segment by Type, the product can be split into

• Non-pharmacological Therapy
• Pharmacological Therapy

Market segment by Application, split into

• Hospital
• Ambulatory Surgical Center
• Home Care

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Insomnia Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Insomnia Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Insomnia Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Insomnia Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Non-pharmacological Therapy
  1.4.3 Pharmacological Therapy
1.5 Market by Application
  1.5.1 Global Insomnia Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Ambulatory Surgical Center
  1.5.4 Home Care
1.6 Coronavirus Disease 2019 (Covid-19): Insomnia Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Insomnia Therapy Industry
    1.6.1.1 Insomnia Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Insomnia Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Insomnia Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Insomnia Therapy Market Perspective (2015-2026)
2.2 Insomnia Therapy Growth Trends by Regions
  2.2.1 Insomnia Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Insomnia Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Insomnia Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Insomnia Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Insomnia Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Insomnia Therapy Players by Market Size
  3.1.1 Global Top Insomnia Therapy Players by Revenue (2015-2020)
  3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Insomnia Therapy Market Concentration Ratio
  3.2.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2019
3.3 Insomnia Therapy Key Players Head office and Area Served
3.4 Key Players Insomnia Therapy Product Solution and Service
3.5 Date of Enter into Insomnia Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Insomnia Therapy Historic Market Size by Type (2015-2020)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2021-2026)

5 INSOMNIA THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Insomnia Therapy Market Size by Application (2015-2020)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Insomnia Therapy Market Size (2015-2020)
6.2 Insomnia Therapy Key Players in North America (2019-2020)
6.3 North America Insomnia Therapy Market Size by Type (2015-2020)
6.4 North America Insomnia Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Insomnia Therapy Market Size (2015-2020)
7.2 Insomnia Therapy Key Players in Europe (2019-2020)
7.3 Europe Insomnia Therapy Market Size by Type (2015-2020)
7.4 Europe Insomnia Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Insomnia Therapy Market Size (2015-2020)
8.2 Insomnia Therapy Key Players in China (2019-2020)
8.3 China Insomnia Therapy Market Size by Type (2015-2020)
8.4 China Insomnia Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Insomnia Therapy Market Size (2015-2020)
9.2 Insomnia Therapy Key Players in Japan (2019-2020)
9.3 Japan Insomnia Therapy Market Size by Type (2015-2020)
9.4 Japan Insomnia Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Insomnia Therapy Market Size (2015-2020)
10.2 Insomnia Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Insomnia Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Insomnia Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Insomnia Therapy Market Size (2015-2020)
11.2 Insomnia Therapy Key Players in India (2019-2020)
11.3 India Insomnia Therapy Market Size by Type (2015-2020)
11.4 India Insomnia Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Insomnia Therapy Market Size (2015-2020)
12.2 Insomnia Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Insomnia Therapy Market Size by Type (2015-2020)
12.4 Central & South America Insomnia Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Merck & Co.
  13.1.1 Merck & Co. Company Details
  13.1.2 Merck & Co. Business Overview and Its Total Revenue
  13.1.3 Merck & Co. Insomnia Therapy Introduction
  13.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2015-2020))
  13.1.5 Merck & Co. Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview and Its Total Revenue
  13.2.3 Sanofi Insomnia Therapy Introduction
  13.2.4 Sanofi Revenue in Insomnia Therapy Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Insomnia Therapy Introduction
  13.3.4 Pfizer Revenue in Insomnia Therapy Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Takeda Pharmaceutical Company Ltd.
  13.4.1 Takeda Pharmaceutical Company Ltd. Company Details
  13.4.2 Takeda Pharmaceutical Company Ltd. Business Overview and Its Total Revenue
  13.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
  13.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020)
  13.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
13.5 Purdue Pharmaceuticals L.P.
  13.5.1 Purdue Pharmaceuticals L.P. Company Details
  13.5.2 Purdue Pharmaceuticals L.P. Business Overview and Its Total Revenue
  13.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
  13.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020)
  13.5.5 Purdue Pharmaceuticals L.P. Recent Development
13.6 Eisai, Co. Ltd.
  13.6.1 Eisai, Co. Ltd. Company Details
  13.6.2 Eisai, Co. Ltd. Business Overview and Its Total Revenue
  13.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
  13.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020)
  13.6.5 Eisai, Co. Ltd. Recent Development
13.7 Meda Consumer Healthcare
  13.7.1 Meda Consumer Healthcare Company Details
  13.7.2 Meda Consumer Healthcare Business Overview and Its Total Revenue
  13.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
  13.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020)
  13.7.5 Meda Consumer Healthcare Recent Development
13.8 Pernix Therapeutics
  13.8.1 Pernix Therapeutics Company Details
  13.8.2 Pernix Therapeutics Business Overview and Its Total Revenue
  13.8.3 Pernix Therapeutics Insomnia Therapy Introduction
  13.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
  13.8.5 Pernix Therapeutics Recent Development
13.9 Vanda Pharmaceuticals
  13.9.1 Vanda Pharmaceuticals Company Details
  13.9.2 Vanda Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
  13.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
  13.9.5 Vanda Pharmaceuticals Recent Development
13.10 ECR Pharmaceuticals
  13.10.1 ECR Pharmaceuticals Company Details
  13.10.2 ECR Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
  13.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
  13.10.5 ECR Pharmaceuticals Recent Development
13.11 Fidia Farmaceutici
  10.11.1 Fidia Farmaceutici Company Details
  10.11.2 Fidia Farmaceutici Business Overview and Its Total Revenue
  10.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
  10.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020)
  10.11.5 Fidia Farmaceutici Recent Development
13.12 Dainippon Sumitomo
  10.12.1 Dainippon Sumitomo Company Details
  10.12.2 Dainippon Sumitomo Business Overview and Its Total Revenue
  10.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
  10.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020)
  10.12.5 Dainippon Sumitomo Recent Development
13.13 Biocodex
  10.13.1 Biocodex Company Details
  10.13.2 Biocodex Business Overview and Its Total Revenue
  10.13.3 Biocodex Insomnia Therapy Introduction
  10.13.4 Biocodex Revenue in Insomnia Therapy Business (2015-2020)
  10.13.5 Biocodex Recent Development
13.14 Eli Lilly and Company
  10.14.1 Eli Lilly and Company Company Details
  10.14.2 Eli Lilly and Company Business Overview and Its Total Revenue
  10.14.3 Eli Lilly and Company Insomnia Therapy Introduction
  10.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020)
  10.14.5 Eli Lilly and Company Recent Development
13.15 Ebb Therapeutics
  10.15.1 Ebb Therapeutics Company Details
  10.15.2 Ebb Therapeutics Business Overview and Its Total Revenue
  10.15.3 Ebb Therapeutics Insomnia Therapy Introduction
  10.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
  10.15.5 Ebb Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Insomnia Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Insomnia Therapy Revenue
Table 3. Ranking of Global Top Insomnia Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-pharmacological Therapy
Table 6. Key Players of Pharmacological Therapy
Table 7. COVID-19 Impact Global Market: (Four Insomnia Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Insomnia Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Insomnia Therapy Players to Combat Covid-19 Impact
Table 12. Global Insomnia Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Insomnia Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Insomnia Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Insomnia Therapy Market Share by Regions (2015-2020)
Table 16. Global Insomnia Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Insomnia Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Insomnia Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Insomnia Therapy Players
Table 23. Global Insomnia Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Insomnia Therapy Market Share by Players (2015-2020)
Table 25. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2019)
Table 26. Global Insomnia Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Insomnia Therapy Product Solution and Service
Table 29. Date of Enter into Insomnia Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Insomnia Therapy Market Size Share by Type (2015-2020)
Table 33. Global Insomnia Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Insomnia Therapy Market Size Share by Application (2015-2020)
Table 35. Global Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Insomnia Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Insomnia Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Insomnia Therapy Market Share (2019-2020)
Table 39. North America Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Insomnia Therapy Market Share by Type (2015-2020)
Table 41. North America Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Insomnia Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Insomnia Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Insomnia Therapy Market Share (2019-2020)
Table 45. Europe Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Insomnia Therapy Market Share by Type (2015-2020)
Table 47. Europe Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Insomnia Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Insomnia Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Insomnia Therapy Market Share (2019-2020)
Table 51. China Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Insomnia Therapy Market Share by Type (2015-2020)
Table 53. China Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Insomnia Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Insomnia Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Insomnia Therapy Market Share (2019-2020)
Table 57. Japan Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Insomnia Therapy Market Share by Type (2015-2020)
Table 59. Japan Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Insomnia Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Insomnia Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Insomnia Therapy Market Share (2019-2020)
Table 63. Southeast Asia Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Insomnia Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Insomnia Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Insomnia Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Insomnia Therapy Market Share (2019-2020)
Table 69. India Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Insomnia Therapy Market Share by Type (2015-2020)
Table 71. India Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Insomnia Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Insomnia Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Insomnia Therapy Market Share (2019-2020)
Table 75. Central & South America Insomnia Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Insomnia Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Insomnia Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Insomnia Therapy Market Share by Application (2015-2020)
Table 79. Merck & Co. Company Details
Table 80. Merck & Co. Business Overview
Table 81. Merck & Co. Product
Table 82. Merck & Co. Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 83. Merck & Co. Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Takeda Pharmaceutical Company Ltd. Company Details
Table 95. Takeda Pharmaceutical Company Ltd. Business Overview
Table 96. Takeda Pharmaceutical Company Ltd. Product
Table 97. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 98. Takeda Pharmaceutical Company Ltd. Recent Development
Table 99. Purdue Pharmaceuticals L.P. Company Details
Table 100. Purdue Pharmaceuticals L.P. Business Overview
Table 101. Purdue Pharmaceuticals L.P. Product
Table 102. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 103. Purdue Pharmaceuticals L.P. Recent Development
Table 104. Eisai, Co. Ltd. Company Details
Table 105. Eisai, Co. Ltd. Business Overview
Table 106. Eisai, Co. Ltd. Product
Table 107. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 108. Eisai, Co. Ltd. Recent Development
Table 109. Meda Consumer Healthcare Company Details
Table 110. Meda Consumer Healthcare Business Overview
Table 111. Meda Consumer Healthcare Product
Table 112. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 113. Meda Consumer Healthcare Recent Development
Table 114. Pernix Therapeutics Business Overview
Table 115. Pernix Therapeutics Product
Table 116. Pernix Therapeutics Company Details
Table 117. Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 118. Pernix Therapeutics Recent Development
Table 119. Vanda Pharmaceuticals Company Details
Table 120. Vanda Pharmaceuticals Business Overview
Table 121. Vanda Pharmaceuticals Product
Table 122. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 123. Vanda Pharmaceuticals Recent Development
Table 124. ECR Pharmaceuticals Company Details
Table 125. ECR Pharmaceuticals Business Overview
Table 126. ECR Pharmaceuticals Product
Table 127. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 128. ECR Pharmaceuticals Recent Development
Table 129. Fidia Farmaceutici Company Details
Table 130. Fidia Farmaceutici Business Overview
Table 131. Fidia Farmaceutici Product
Table 132. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 133. Fidia Farmaceutici Recent Development
Table 134. Dainippon Sumitomo Company Details
Table 135. Dainippon Sumitomo Business Overview
Table 136. Dainippon Sumitomo Product
Table 137. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 138. Dainippon Sumitomo Recent Development
Table 139. Biocodex Company Details
Table 140. Biocodex Business Overview
Table 141. Biocodex Product
Table 142. Biocodex Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 143. Biocodex Recent Development
Table 144. Eli Lilly and Company Company Details
Table 145. Eli Lilly and Company Business Overview
Table 146. Eli Lilly and Company Product
Table 147. Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 148. Eli Lilly and Company Recent Development
Table 149. Ebb Therapeutics Company Details
Table 150. Ebb Therapeutics Business Overview
Table 151. Ebb Therapeutics Product
Table 152. Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020) (Million US$)
Table 153. Ebb Therapeutics Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Insomnia Therapy Market Share by Type: 2020 VS 2026
Figure 2. Non-pharmacological Therapy Features
Figure 3. Pharmacological Therapy Features
Figure 4. Global Insomnia Therapy Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Ambulatory Surgical Center Case Studies
Figure 7. Home Care Case Studies
Figure 8. Insomnia Therapy Report Years Considered
Figure 9. Global Insomnia Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Insomnia Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Insomnia Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Insomnia Therapy Market Share by Players in 2019
Figure 14. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2019
Figure 16. North America Insomnia Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Insomnia Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Insomnia Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Insomnia Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Insomnia Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Insomnia Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Insomnia Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 25. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 29. Takeda Pharmaceutical Company Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 31. Purdue Pharmaceuticals L.P. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 33. Eisai, Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 35. Meda Consumer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 37. Pernix Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 39. Vanda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 41. ECR Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 43. Fidia Farmaceutici Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 45. Dainippon Sumitomo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 47. Biocodex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 49. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 51. Ebb Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed